ArticleMaterials (Basel, Switzerland)2025
The Impact of Physical Form on the Biocompatibility of Poly(3-hexylthiophene-2,5-diyl).
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Poly(3-hexylthiophene-2,5-diyl) (P3HT) is a semiconducting, electron donor polymer which, in addition to its intensive use in optoelectronic devices, is increasingly investigated in biological systems. However, there are conflicting reports about the biocompatibility of P3HT, and no direct comparison between P3HT films and P3HT nanoparticles has been conducted. In this context, we investigated the viability of bEnd.3 endothelial cells when such cells are grown onto P3HT films or incubated with P3HT nanoparticles and subjected to trains of moderate power density, relatively long light pulses. We observed that, while P3HT films do not decrease the viability of bEnd.3 cells at all, P3HT nanoparticles lower the viability of bEND.3 cells by ~20%, when the nanoparticles also contain [6,6]-phenyl-C61-butyric acid methyl ester (PCBM) as electron acceptor, and by ~30%, when the nanoparticles do not contain PCBM. Interestingly, the used photoexcitation protocol did not impact the biocompatibility of the P3HT-based materials. The obtained results reveal that (i). nanostructuring has a detrimental impact on the compatibility of P3HT with bEND.3 endothelial cells, and (ii). P3HT-based materials can be safely combined with light when used in biological systems because light, as used in the present study, does not alter the biocompatibility of such materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.